HOME >> MEDICINE >> NEWS
Patent laws and US trade agreements are hindering access to HIV treatment

International patent laws and US-negotiated trade agreements are impeding access to life-saving HIV medicines (antiretroviral therapy, ART), say researchers in a policy paper in PLoS Medicine.

"Multinational pharmaceutical companies, World Trade Organization members, US and European Union trade representatives, and health-care activists have clashed over provision of ART to people living with AIDS in developing countries," say Michael Westerhaus (Brigham and Women's Hospital) and Arachu Castro (Harvard Medical School).

Activists contend that current intellectual property law impedes the purchase of ART in resource-poor settings and allows pharmaceutical companies to monopolize the markets of developing nations. "As a result,' say the authors, "the cost of these treatments far exceeds personal and national budgets, and the development of more affordable generic alternatives is proscribed. "

In addition, they say, "the US has embarked on an aggressive campaign to liberalize trade through bilateral, regional, and multilateral trade agreements and this campaign also has an impact on access to ART. These agreements have conditioned liberalized trade upon the expansion of intellectual property law for multinational pharmaceutical companies holding patents for antiretrovirals among other essential medicines."

The agreements, say Westerhaus and Castro, extend the protection of patents beyond the current 20-year period, freeze generic manufacturing of ART, protect the manufacturers' drug testing data for five years (a practice known as data exclusivity), and limit options for poor countries to manufacture their own ART during a public health emergency.

Citation: Westerhaus M, Castro A (2006) How do intellectual property law and international trade agreements affect access to antiretroviral therapy? PLoS Med 3(8): e332.

PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT:

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
7-Aug-2006


Page: 1 2 3

Related medicine news :

1. ASTRO annual meeting again named a fastest growing tradeshow
2. Surgical instruments may not be fair trade
3. EUs free trade rules exacerbate alcohol-related harm
4. WHO must prepare health ministries for trade liberalisation
5. Book Asbestos and Fire explores risk trade-offs
6. Counting the human cost of international trade
7. AstraZeneca and M. D. Anderson Cancer Center form umbrella scientific collaboration agreements
8. Survey of academic medical centers standards for clinical-trial agreements with industry
9. Asia Pacific Family Medicine moves to BioMed Centrals open access platform
10. Parents of chronically ill kids are helped by better access to federal and employer leave
11. ACP supports improved access to information on relative strengths and weaknesses

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/20/2017)... ... August 20, 2017 , ... Are you an adult with gluten intolerance ... you may be interested in participating in a research study that focuses on family ... understand more about the relational aspects of adults who have gluten sensitivities who cohabitate ...
(Date:8/19/2017)... York (PRWEB) , ... August 19, 2017 , ... ... has announced that it is the first organization with pending recognition status from ... Diabetes Prevention Program (“DPP”) via group telehealth classes and live video conferencing. ...
(Date:8/19/2017)... Fla. (PRWEB) , ... August 19, 2017 , ... ... Taufiq Ahmed, M.D., has joined its Orlando location as an interventional pain management ... anesthesiology, a focus on the treatment of migraine headaches, and significant experience in ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance ... a new charity drive to generate community support for efforts to educate the local ... and treatments for all types of cancer. , Each day in America, roughly ...
Breaking Medicine News(10 mins):
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
(Date:8/7/2017)... 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s ... ended June 30, 2017.  All comparisons, unless otherwise noted, are ... Second Quarter 2017 Highlights include: ... million, an increase of 3.5% Total prescriptions ... margin of 7.5% versus 7.6% Gross ...
Breaking Medicine Technology:
Cached News: